PART ONE of TWO: With China and other European countries thriving, why is Russian pharma/biotech still invisible? A brief examination of why, and whether change is likely anytime soon.
Russia’s pharmaceutical market-2018 Is the Russian pharmaceutical market on course for rapid growth, or will it remain a moribund market plagued by stagnation, decay and persistent drug shortages? The Russian… Read more »